The Weekly Litigation News Digest is now live. Subscribe now

Alfasigma competitive analysis

Loading summary...

Explore patent oppositions filed by Alfasigma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Storage Stable Composition Comprising Rifaximin AlphaSANDOZSep 22, 2022
Pharmaceutical Composition Containing Rifaximin Alpha & DeltaSANDOZMar 21, 2022
Oral Dosage Form Comprising Rifaximin In Form BetaSANDOZAug 27, 2020
Storage Stable Composition Comprising Rifaximin AlphaSANDOZJan 24, 2020
Pharmaceutical Composition Containing Rifaximin Alpha&DeltaSANDOZJun 12, 2019

Explore Alfasigma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
Jul 30, 2025Process For Mesalazine Solid Formulations1
Dec 20, 2023Pharmaceutical Compositions Comprising A Jak Inhibitor3
Nov 1, 2017Pharmaceutical Formulations Containing Rifaximin, Processes For Their Obtainment And Method Of Treating Intestinal Disease1
Jun 7, 2017Sulodexide For Use In The Treatment Of Pathologies Wherein Metalloproteinases Are Involved2
Apr 19, 2017Use Of Polyols To Obtain Stable Polymorphous Forms Of Rifaximin3

Latest PTAB cases involving Alfasigma

Discover the latest PTAB cases involving Alfasigma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Alfasigma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ALFASIGMA510 - -
BOTTI & FERRARI14 - - -
POLPHARMA32 - - -
SANDOZ1191619 -